Abstract:OBJECTIVE:To investigate the expression level of vascular endothelial growth factor (VEGF) in serum of patients with multiple myeloma (MM) and its possible clinical significance. METHODS:68 patients with MM who were admitted to The First Affiliated Hospital of Bengbu Medical College from July 2019 to June 2020 were collected. The expression level of VEGF was detected by VEGF enzyme-linked immunosorbent assay, the correlation of VEGF expression with serous effusion in MM was explored, and the relationship between VEGF expression level and clinical features and prognosis of patients with MM was analyzed. RESULTS:The positive rate of VEGF was 36.76% (25/68) in 68 patients with MM, 10 cases (58.82%, 10/17) were VEGF positive in 17 MM patients with serous effusion. The expression level of VEGF in patients with positive serous effusion was significantly higher than that in patients with negative serous effusion (P<0.05); the expression level of VEGF in MM patients of the newly diagnosed and untreated group was significantly higher than that in the remission group after treatment (P<0.05), but there was no significant difference in the expression level of VEGF between the newly diagnosed group and the refractory/relapsed (R/R) group (P>0.05). Among 68 patients with MM, 48 patients underwent FISH examination, 28 cases had normal karyotype (58.33%), and 20 cases had abnormal karyotype (41.67%). The abnormal karyotype was mainly IgH rearrangement, with a total of 10 cases (20.83%); other cases: 1q21+, del (13q14), del (17p13) were 3 cases (6.25%), 2 cases (4.17%), 7 cases (14.58%), respectively. Compared with VEGF- group, the incidence of IgH rearrangement and del (17p13) in VEGF+ group was higher [IgH rearrangement: 35% vs 10.71%, P=0.043; del(17p13): 30% vs 3.57%, P=0.011]. Compared with negative serous effusion group, the incidence of del (17p13) in positive serous effusion group was higher (31.25% vs 6.25%, P=0.021). The proportion of patients with positive VEGF and serous effusion was 14.71% (10/68), and the proportion of patients with negative VEGF and negative serous effusion was 52.94% (36/68). There was a correlation between serous effusion and VEGF expression (r=0.264, P=0.029). CONCLUSION:The prognosis of MM patients with serous effusion is poor, and the expression of VEGF in serum of these patients is significantly high. The increased VEGF may be involved in the occurrence and development of serous effusion.

Study on Expression of Vascular Endothelial Growth Factor and Angiogenesis in Multiple Myeloma

[Expression and Clinical Significance of Vascular Endothelial Growth Factor and Its Receptors in Multiple Myeloma].

The Clinical Significance of Angiogenesis in Multiple Myeloma

Clinial Significance of Angiogenic Factors VEGF,bFGF,HGF Serum Concentrations in Multiple Myeloma

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

Serum level of vascular endothelial growth factor in hematological malignancies

Correlation Between Expression of CXCL12, CXCR4, VEGF, MVD and Prognosis in Patients with Multiple Myeloma

The advanced research on angiogenesis in multiple myeloma bone marrow microenvironment

Expressions of vascular endothelial growth factor and cyclooxygenase-2 in patients with multiple myeloma and its significance]

Correlation of p53 expression and angiogenesis in bone marrow biopsies of multiple myeloma

Relationship between Argonaute 2 expression and angiogenesis of multiple myeloma

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Human Malignant Melanoma and Their Relation to Angiogenesis

Expression and Pathogenesis of VCAM-1 and VLA-4 Cytokines in Multiple Myeloma

In Vitro Study of Human Multiple Myeloma Cell Transfected with Soluble Vascular Endothelial Growth Factor Receptor-1 Gene

[Expression Level and Clinical Significance of VEGF, IL-17, Β2-Mg and IL-35 in Patients with Multiple Myeloma].

Study on Bone Marrow Angiogenesis in Patients with Acute Leukemia

Angiogenesis and multiple myeloma: Exploring prognostic potential of adrenomedullin

[Correlation of VEGF Expression with Serous Effusion in Multiple Myeloma Patients].

Study of Angiogenesis in Bone Marrow of Patients with Acute Leukemia

Study on Expression of VDAC1 Gene in Patients with Multiple Myeloma

EXPRESSION AND ITS SIGNIFICANCE OF miRNA-19 IN MULTIPLE MYELOMA